Open AccessEvaluation of babies with retinopathy of prematurity following intravitreal bevacizumab administration
Author(s) -
Özlem Şahin
Publication year - 2023
Publication title -
i̇stanbul kuzey klinikleri
Language(s) - English
Resource type - Journals
ISSN - 2148-4902
DOI - 10.14744/nci.2022.22308
Subject(s) - retinopathy of prematurity , bevacizumab , medicine , blood pressure , incidence (geometry) , pediatrics , surgery , gestational age , chemotherapy , pregnancy , genetics , biology , physics , optics
In Turkiye, the increased likelihood of survival of small premature babies has resulted in a higher incidence of retinopathy of prematurity (ROP), which causes severe visual impairment in childhood. Early diagnosis and timely and proper treatment of ROP can prevent vision loss. This paper discusses cases of ROP treated with bevacizumab.